AMILI
PrivateLast Round
Series A
Extension
May 29, 2023
Total Funding Raised
$10.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
AMILI operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Series A Extension round in May 2023.
AMILI is a biotechnology company that provides gut microbiome data insights, analytics, tests, and therapeutics, and operates Southeast Asia's first gut microbiome transplant bank.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AMILI Comparables
Compare AMILI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GenieBiome | 81% | |
| Leucine Rich Bio | 81% | |
| Biome Diagnostics | 77% |
For institutional investors. Book with your work email.
AMILI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | May 29, 2023 | ||||
| Series A | Jun 15, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AMILI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| G. K. Goh Holdings Pte. Ltd. | Series A |
| Capital Code | Series A |
| SEEDS Capital | Series A |
| Blue7 | Series A |
| Vulcan Capital | Series A |
| East Ventures | Series A Extension |
| Elang Mahkota Teknologi | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 192% MoM, reaching 39.2K.
- Jul 26, 2026
Monthly visitors grew 119% MoM, from 6.1K to 13.4K.
For institutional investors. Book with your work email.
AMILI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AMILI's valuation, stock price, and market status.
Is AMILI a public or private company?
AMILI is a private company.
What is the current stock price of AMILI?
AMILI is a private company, so its shares have no public market price. Caplight tracks AMILI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AMILI worth (valuation)?
Valuation information for AMILI is not publicly available.
Can I buy AMILI stock?
AMILI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AMILI's last funding round?
AMILI's most recent funding round was Series A Extension on May 29, 2023.
Who are the main investors in AMILI?
Key investors in AMILI include Vulcan Capital, East Ventures, Cercano Management.
Will AMILI IPO soon?
No public IPO plans have been announced for AMILI.
How can I track AMILI secondary market activity?
Caplight tracks bids, offers, and trades in AMILI's shares on secondary markets.